Literature DB >> 23634408

Pathological Fractures in Primary Non-Hodgkin's Lymphoma of the Bone: A Case Series with Review of the Literature.

Yasir Salam Siddiqui1, Abdul Qayyum Khan, Mka Sherwani.   

Abstract

Primary non-Hodgkin's lymphoma of bone (PLB) is a rare entity. Patients generally present with localized bone pain and, less frequently, soft-tissue swelling or a palpable mass. Pathological fracture of the proximal femur and proximal humerus secondary to soft-tissue tumours is well documented in the literature; however, lymphomas presenting primarily at these sites with pathological fracture is unusual. A review of the world literature shows that the incidence of skeletal manifestation from NHL is less than 5%, and in all these cases, bony involvement was reported many years after presentation of the primary cancer. Histopathologically, PLB usually represents diffuse large B-cell lymphoma. We report our experience with two cases of Primary non-Hodgkin's lymphoma of proximal femur and proximal humerus with pathological fracture and their management.

Entities:  

Keywords:  Chemotherapy; Pathological fractures; Primary non-Hodgkin’s lymphoma of bone

Year:  2013        PMID: 23634408      PMCID: PMC3616568          DOI: 10.7860/JCDR/2013/3948.2809

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  7 in total

1.  Primary reticulum-cell sarcoma of bone; summary of 37 cases.

Authors:  B L COLEY; N L HIGINBOTHAM; H P GROESBECK
Journal:  Radiology       Date:  1950-11       Impact factor: 11.105

2.  A clinicopathological retrospective study of 131 patients with primary bone lymphoma: a population-based study of successively treated cohorts from the British Columbia Cancer Agency.

Authors:  K M Ramadan; T Shenkier; L H Sehn; R D Gascoyne; J M Connors
Journal:  Ann Oncol       Date:  2006-10-03       Impact factor: 32.976

3.  Primary lymphoma of bone: the use of MRI in pretreatment evaluation.

Authors:  M Salter; R J Sollaccio; W K Bernreuter; B Weppelmann
Journal:  Am J Clin Oncol       Date:  1989-04       Impact factor: 2.339

4.  Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods?

Authors:  K Spaepen; S Stroobants; P Dupont; S Van Steenweghen; J Thomas; P Vandenberghe; L Vanuytsel; G Bormans; J Balzarini; C De Wolf-Peeters; L Mortelmans; G Verhoef
Journal:  J Clin Oncol       Date:  2001-01-15       Impact factor: 44.544

5.  Primary bone lymphoma: a report of two cases and review of the literature.

Authors:  Tejinder Singh; C T Satheesh; K C Lakshmaiah; T M Suresh; Govind K Babu; D Lokanatha; Linu A Jacob; Rajashekar Halkud
Journal:  J Cancer Res Ther       Date:  2010 Jul-Sep       Impact factor: 1.805

6.  Primary lymphoma of bone in children: analysis of treatment results with adriamycin, prednisone, Oncovin (APO), and local radiation therapy.

Authors:  J S Loeffler; N J Tarbell; H Kozakewich; J R Cassady; H J Weinstein
Journal:  J Clin Oncol       Date:  1986-04       Impact factor: 44.544

Review 7.  Primary bone lymphoma: radiographic-MR imaging correlation.

Authors:  Anant Krishnan; Ali Shirkhoda; Jamshid Tehranzadeh; Ali R Armin; Ronald Irwin; Kimberly Les
Journal:  Radiographics       Date:  2003 Nov-Dec       Impact factor: 5.333

  7 in total
  3 in total

1.  Primary bone lymphomas-Clinical cases and review of literature.

Authors:  Anshu Jain; Kiran Alam; Veena Maheshwari; Roobina Khan; Hage Nobin; Varsha Narula
Journal:  J Bone Oncol       Date:  2013-07-31       Impact factor: 4.072

2.  Epstein-Barr Virus-Positive Not Otherwise Specified (EBV+ NOS) Lymphoma Presentation of Primary Bone Tumor Underlying a Pathological Fracture.

Authors:  Abhishek Tippabhatla; Rediet T Atalay; Alex Gyftopoulos; Girma M Ayele; Miriam B Michael
Journal:  Cureus       Date:  2022-06-26

3.  Successful Management of a Rare Case of Humerus Non-Hodgkin's Lymphoma in Rapid Progress.

Authors:  Shu-Zhong Liu; Xi Zhou; An Song; Yi-Peng Wang; Yong Liu
Journal:  Chin Med J (Engl)       Date:  2018-07-20       Impact factor: 2.628

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.